Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas-Reference-Cited by-同舟云学术

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

Published:2011-06 Issue:6 Volume:12 Page:583-593
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

van den Bent MJ,Wefel JS,Schiff D,Taphoorn MJB,Jaeckle K,Junck L,Armstrong T,Choucair A,Waldman AD,Gorlia T,Chamberlain M,Baumert BG,Vogelbaum MA,Macdonald DR,Reardon DA,Wen PY,Chang SM,Jacobs AH

Publisher

Elsevier BV

Subject

Oncology

Reference91 articles.

1. A randomized trial on dose-response in radiation therapy of low grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 2284;Karim;Int J Radiat Oncol Biol Phys,1996

2. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial;van den Bent;Lancet,2005

3. A prospective randomized trial of low versus high dose radiation in adults with a supratentorial low grade glioma: initial report of a NCCTG-RTOG-ECOG study;Shaw;J Clin Oncol,2002

4. Prognostic factors for survival in adult patients with cerebral low-grade glioma;Pignatti;J Clin Oncol,2002

5. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults;Chang;J Neurosurg,2008

Cited by 515 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A perioperative study of Safusidenib in patients with IDH1 -mutated glioma;Future Oncology;2024-08-14

2. Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors;npj Precision Oncology;2024-08-14

3. Tumor-related epilepsy in high-grade glioma: a large series survival analysis;Journal of Neuro-Oncology;2024-08-05

4. Unveiling hierarchy and spatial distribution of O⁶‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas;Cancer Science;2024-08-05

5. Treatment of IDH-mutant glioma in the INDIGO era;npj Precision Oncology;2024-07-19